trending Market Intelligence /marketintelligence/en/news-insights/trending/CdfH6DLeLMuwYJLxjD4f_Q2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Former FDA commissioner joins Malin as chief medical adviser

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Former FDA commissioner joins Malin as chief medical adviser

Malin Corp. PLC appointed Andrew von Eschenbach to serve as chief medical adviser.

Von Eschenbach was previously an advisory partner to Malin. He served as the commissioner of the U.S. Food and Drug Administration from 2006 to 2009. Prior to that, he was the director of the National Cancer Institute at the National Institute of Health.

Von Eschenbach is the president of Samaritan Health Initiatives Inc.